News
A pronouncement from President Trump about the category drove their share prices down, although not to bargain-basement ...
Even if the order takes effect, it will do nothing to address the root causes of the problem it purports to solve.
People prescribed GLP-1 agents liraglutide (Saxenda) or semaglutide for weight loss decreased their alcohol intake by almost ...
While the drugs certainly contribute to weight loss and health gains, they also cause a decline in muscle that some doctors ...
Recent health briefs reveal significant developments in the pharmaceutical sector. Key highlights include Trump's order ...
For the 2025 outlook, Novo Nordisk now expects 13-21% revenue increase at constant exchange rates (CER). Operating profit is ...
President Donald Trump's executive order directs pharmaceutical companies to lower their prices to levels closer to those ...
Ever since the pharmaceutical company Novo Nordisk realized that GLP-1 drugs were useful for more than diabetes, doctors and ...
Health-care companies rose sharply after President Trump signed an executive order designed to lower what Americans pay for prescription drugs that offered pharmaceutical companies room for ...
The Trump administration on Monday singled out powerful new weight-loss drugs including Wegovy and Zepbound as targets in its ...
The Trump administration is pushing for reduced prices on weight-loss drugs like Wegovy and Zepbound, citing stark pricing ...
As a Biden administration ban on so-called “junk fees” took effect Monday, Ticketmaster said it would start displaying the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results